Swedish and international institutions have subscribed Euro 132 million for InnovationsKapital's new fund
IRegent, Jim Mellon’s Hong Kong investment group, provides initial backing for a new genetic medicine fund.
John Major will be the firm's European chairman. Christopher Finn explains why, and looks at other developments inside the firm.
Cisco and Infineon contributed to the $220m fund, which has so far made five investments.
Epartners has given back its e-money. The firm has decided it cannot invest $520m of the $650m fund it raised for internet companies last July and will return it to investors including Morgan Stanley and Softbank.
France’s oldest VC has raised a new fund of E330m for investment in early-stage biotech and IT companies.
The venture capitalist has announced a $950m fund aimed at biotech and IT, but not the internet. Institutionals on both sides of the Atlantic contributed to the fund.
Money from Merlin Bioscience, Citigroup, Verus and 3i; initial close from Vertex.
Electra Partners intends to invest in approximately 15 companies over the next three to four years.
Former analyst Michael Wand brings ‘deep insight into the software landscape' to the group.